2,171 Shares in Humana Inc. (NYSE:HUM) Bought by Symmetry Investments LP

Symmetry Investments LP bought a new stake in Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 2,171 shares of the insurance provider's stock, valued at approximately $551,000.

A number of other hedge funds have also recently made changes to their positions in the company. FPC Investment Advisory Inc. acquired a new stake in Humana during the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana during the fourth quarter valued at $30,000. LFA Lugano Financial Advisors SA lifted its holdings in shares of Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management bought a new stake in shares of Humana in the fourth quarter worth $33,000. Finally, Transce3nd LLC acquired a new stake in Humana in the fourth quarter valued at $38,000. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HUM has been the topic of a number of analyst reports. Morgan Stanley reduced their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Mizuho boosted their target price on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Barclays upped their target price on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research report on Friday, April 11th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $284.90.

Humana Trading Up 5.3 %

NYSE HUM opened at $258.87 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a fifty day simple moving average of $265.74 and a 200 day simple moving average of $270.19. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The firm has a market capitalization of $31.24 billion, a P/E ratio of 26.02, a PEG ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date is Friday, June 27th. Humana's payout ratio is 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.